Related Experiment Video
Updated: Nov 5, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
PERSONALIZED NEOANTIGEN VACCINE AGAINST CANCER
1Juraj Dobrila University of Pula, Faculty of Medicine, Zagrebačka 30, 52 100 Pula, Croatia.
Abstract:
No significant therapeutic solutions for advanced cancer are available to date. However, an old idea based on usage of tumor-specific antibodies as the basis for a new vaccination form in patients with advanced tumors, has attracted recent research and is possible due to development of personalized neoantigenic vaccines. Each tumour has indeed, its own mutation content, only a small percentage are shared between patients. Technological advances and the established genome databases, allowed for a rapid mapping of mutations in the genome. The latter allows for a rational selection of targets for personalized vaccines and on-demand production of customized therapy according to the patient's individual tumour properties. This article accordingly, summarizes basic principles of vaccines for personalized neoantigens, translational research and clinical studies related to these vaccines. Finally, the future of such therapy with personalized vaccines is discussed.
Insights
Personalized neoantigenic vaccines offer a novel cancer treatment strategy by targeting unique tumor mutations. This approach enables customized therapies for advanced cancers, representing a significant advancement in oncology.
Area of Science:
- Oncology
- Immunology
- Genomics
Background:
- Advanced cancer lacks effective therapeutic solutions.
- Personalized neoantigenic vaccines leverage tumor-specific mutations for targeted therapy.
Purpose of the Study:
- To summarize the principles of personalized neoantigen vaccines.
- To review translational research and clinical studies.
- To discuss the future of this therapeutic approach.
Main Methods:
- Utilizing advances in genomic sequencing to map individual tumor mutations.
- Selecting neoantigens based on unique tumor genetic profiles.
- On-demand production of customized cancer vaccines.
Main Results:
- Technological advancements enable rapid mutation mapping.
- Rational selection of neoantigen targets is now feasible.
- Personalized vaccines can be produced based on individual tumor properties.
Conclusions:
- Personalized neoantigen vaccines represent a promising frontier in advanced cancer treatment.
- This approach holds potential for customized and effective cancer immunotherapies.
- Further research and clinical studies are crucial for realizing the full potential of neoantigen vaccines.
More Related Videos
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

